SIED-GISCOR recommendations for colonoscopy in screening programs: Part I - DiagnosticDIGESTIVE AND LIVER DISEASEIF3.82024-08-014PRE
RE: A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for HemoglobinJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEIF7.22015-10-164OAAI
The impact of immunochemical faecal occult blood testing on colorectal cancer incidenceDIGESTIVE AND LIVER DISEASEIF3.82014-01-01108PREAI
Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screeningCLINICAL CHEMISTRY AND LABORATORY MEDICINEIF3.72014-01-0160OAAI
Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?BRITISH JOURNAL OF CANCERIF6.82009-01-1389OAAI
Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screeningGASTROENTEROLOGYIF25.12007-06-01224OA
Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programmeBRITISH JOURNAL OF CANCERIF6.82007-04-2428OAAI
Gastric cancer after positive screening faecal occult blood testing and negative assessmentDIGESTIVE AND LIVER DISEASEIF3.82007-04-0128PREAI
Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programmeBRITISH JOURNAL OF CANCERIF6.82007-01-0976OAAI
Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: The district of Florence experienceINTERNATIONAL JOURNAL OF CANCERIF4.72001-04-0178OAAI